Predictive value of baseline patient-rated treatment bother for early anastrozole discontinuation in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Fengmin Zhao, John Peipert, Vered Stearns, Victor Tsu-Shih Chang, Opeyemi Jegede, Edward Ip, Ju-Whei Lee, Nathaniel S. O'Connell, Noah Graham, Norah Lynn Henry, Charles L. Loprinzi, Patrick J. Flynn, Michael Jordan Fisch, Ilana F. Gareen, Ruth C Carlos, Mary Lou Smith, David Cella, Joseph A. Sparano, Robert James Gray, Lynne I. Wagner
Institutions: Dana-Farber Cancer Institute, Northwestern University, Johns Hopkins University, VA New Jersey Health Care System, Wake Forest University Health Sciences, Wake Forest University, University of Michigan, Mayo Clinic, Metro-Minnesota Community Oncology Research Consortium, NRG Oncology, Brown University, U-M Rogel Cancer Center, Research Advocacy Network, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4281744117